Literature DB >> 20495068

PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals.

Damian Kovalovsky1, Eric S Alonzo, Olisambu U Uche, Maggie Eidson, Kim E Nichols, Derek B Sant'Angelo.   

Abstract

The broad complex, tramtrack, bric-a-brac-zinc finger (BTB-ZF) transcription factor promyelocytic leukemia zinc finger (PLZF) is required for development of the characteristic innate/effector functions of NKT cells. In this study, we report the characterization and functional analysis of transgenic mouse T cells with forced expression of PLZF. PLZF expression was sufficient to provide some memory/effector functions to T cells without the need for Ag stimulation or proliferation. The acquisition of this phenotype did not require the proliferation typically associated with T cell activation. Furthermore, PLZF transgenic cells maintained a diverse TCR repertoire, indicating that there was no preferential expansion of specific clones. Functionally, PLZF transgenic CD4 and CD8 lymphocytes were similar to wild type memory cells, in that they had similar requirements for costimulation and exhibited a similar pattern of cytokine secretion, with the notable exception that transgenic T cells produced significantly increased levels of IL-17. Whereas transgene-mediated PLZF expression was not sufficient to rescue NKT cell development in Fyn- or signaling lymphocytic activation-associated protein (SAP)-deficient mice, the acquisition of memory/effector functions induced by PLZF in conventional T cells was independent of Fyn and SAP. These data show that PLZF is sufficient to promote T cell effector functions and that PLZF acts independently of SAP- and Fyn-mediated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20495068     DOI: 10.4049/jimmunol.1000776

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

Review 1.  Selection of self-reactive T cells in the thymus.

Authors:  Gretta L Stritesky; Stephen C Jameson; Kristin A Hogquist
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

Review 2.  Making memory at birth: understanding the differentiation of natural killer T cells.

Authors:  Isaac Engel; Mitchell Kronenberg
Journal:  Curr Opin Immunol       Date:  2012-02-02       Impact factor: 7.486

Review 3.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

4.  Induction and maintenance of IL-4 expression are regulated differently by the 3' enhancer in CD4 T cells.

Authors:  M Hanief Sofi; Yu Qiao; K Mark Ansel; Masato Kubo; Cheong-Hee Chang
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

Review 5.  Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans.

Authors:  Leonid S Metelitsa
Journal:  Clin Immunol       Date:  2010-11-20       Impact factor: 3.969

6.  Enhanced oxidative phosphorylation in NKT cells is essential for their survival and function.

Authors:  Ajay Kumar; Kalyani Pyaram; Emily L Yarosz; Hanna Hong; Costas A Lyssiotis; Shailendra Giri; Cheong-Hee Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-25       Impact factor: 11.205

Review 7.  Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions.

Authors:  Patrick J Brennan; Manfred Brigl; Michael B Brenner
Journal:  Nat Rev Immunol       Date:  2013-01-21       Impact factor: 53.106

8.  Zbtb1 Safeguards Genome Integrity and Prevents p53-Mediated Apoptosis in Proliferating Lymphoid Progenitors.

Authors:  Xin Cao; Ying Lu; Xianyu Zhang; Damian Kovalovsky
Journal:  J Immunol       Date:  2016-07-08       Impact factor: 5.422

Review 9.  ID'ing innate and innate-like lymphoid cells.

Authors:  Mihalis Verykokakis; Erin C Zook; Barbara L Kee
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

Review 10.  Genetically engineered donor T cells to optimize graft-versus-tumor effects across MHC barriers.

Authors:  Arnab Ghosh; Amanda M Holland; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.